Chairman and CEO
MedAlliance
Nyon, Vaud, Switzerland
Jeffrey Jump is Chairman and CEO of MedAlliance, a specialist in the development of treatments for coronary & peripheral artery disease. He has nearly 40 years’ experience of the international medical devices industry, 15 years of which have been at Board level. Jeffrey was formerly CEO of Biosensors, where he spent 13 years during which the company grew from a start-up to become the 4th largest supplier of cardiac drug eluting stents. He served as a Board Director and Chairman of Biosensors Europe. Jeffrey has also been a Non-Executive Director of various medical device companies including Symetis (Boston Scientific), PneumRx (BTG), Maya (Covidien), Benechill, Anecova, Impulse Dynamics & Veryan (Osuka). He has also been Chairman of both Combioxin S.A. (Eagle Pharmaceuticals) & Aleva Neuro SA. Jeffrey is currently serving as an Independent Chairman of TexRay & Transluminal/Circlage.
Disclosure information not submitted.
Panel Discussion: Will DCB Play a Role for Coronary Application in the US?
Sunday, March 10, 2024
10:55 AM – 11:10 AM ET